Zim Laboratories Limited has informed the Exchange regarding allotment of 4764497 securities pursuant to Preferential Issue at its meeting held on March 13, 2026

Zim Laboratories has allotted 47.64 lakh equity shares to Florintree Trinex LLP through a preferential issue on a private placement basis. The shares were issued at Rs 73.46 each (a premium of Rs 63.46 over the Rs 10 face value), bringing the total raise to roughly Rs 35 crore in cash. Florintree Trinex LLP, a non-promoter entity, did not hold any shares before and now owns 8.91% of the company post-allotment. Following this, the company's paid-up equity capital has gone up from Rs 48.74 crore to Rs 53.50 crore (share count rose from 4.87 crore to 5.35 crore shares). The new shares will rank equally with existing shares. This follows in-principle approvals from NSE and BSE received on February 27, 2026.